GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DongKook Pharmaceutical Co Ltd (XKRX:086450) » Definitions » YoY EPS Growth

DongKook Pharmaceutical Co (XKRX:086450) YoY EPS Growth : -5.42% (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is DongKook Pharmaceutical Co YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. DongKook Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Dec. 2024 was -5.42%.

DongKook Pharmaceutical Co's Earnings per Share (Diluted) for the three months ended in Dec. 2024 was ₩192.00.


DongKook Pharmaceutical Co YoY EPS Growth Historical Data

The historical data trend for DongKook Pharmaceutical Co's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DongKook Pharmaceutical Co YoY EPS Growth Chart

DongKook Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 396.82 -9.99 5.06 -10.82 29.67

DongKook Pharmaceutical Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.33 22.91 36.94 59.04 -5.42

DongKook Pharmaceutical Co YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

DongKook Pharmaceutical Co's YoY EPS Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EPS Growth (A: Dec. 2024 )
=(Earnings per Share (Diluted) (A: Dec. 2024 )-Earnings per Share (Diluted) (A: Dec. 2023 ))/ | Earnings per Share (Diluted) (A: Dec. 2023 ) |
=(1368-1055)/ | 1055 |
=29.67 %

DongKook Pharmaceutical Co's YoY EPS Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EPS Growth (Q: Dec. 2024 )
=(Earnings per Share (Diluted) (Q: Dec. 2024 )-Earnings per Share (Diluted) (Q: Dec. 2023 )) / | Earnings per Share (Diluted) (Q: Dec. 2023 )) |
=(192-203)/ | 203 |
=-5.42 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DongKook Pharmaceutical Co YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of DongKook Pharmaceutical Co's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


DongKook Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Dongkook Building 997-8 Daechi 3-dong, Kangnam-gu, Seoul, KOR, 135-502
DongKook Pharmaceutical Co Ltd is a part of the healthcare industry based in Korea. Being a pharmaceutical company, its activities are focused on the research and development of drugs. The company produces superior medicines used favorably by consumers such as Madecassol, which is a drug for wounds and Oramedy, which is a drug for treating stomatitis. It also owns a prefilled syringe system in its second factory, through which it produces various kinds of ultramodern injection agents.

DongKook Pharmaceutical Co Headlines

No Headlines